| Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
|---|---|---|---|---|---|---|---|---|---|---|---|
| JYHB2200426 | 二甲双胍恩格列净片（IV） | empagliflozin;metformin hydrochloride | Tablet | Chemical Drugs | Supplementary Application | 2022-08-08 | Boehringer Ingelheim International GmbH | view |